Granules Pharma gets USFDA nod for genetic disorder drug Colchicine Medical Dialogues Bureau8 Feb 2020 5:00 AM "The US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc, a...